Erythropoietin Therapy Decreased Tissue Factor, Its Pathway Inhibitor, and Oxidative Stress in Peritoneal Dialysis Patients with Diabetes

Publisher： Karger

E-ISSN： 1660-2110|107|1|c20-c25

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.107, Iss.1, 2007-07, pp. : c20-c25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between nitric oxide and oxidative stress in continuous ambulatory peritoneal dialysis patients peritonitis

By Duranay M.   Yilmaz F. M.   Yilmaz G.   Akay H.   Parpucu H.   Yücel D.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 6, 2007-01 ,pp. : 654-660

Informa Healthcare

Access to resources Recommend Favorite

New insights into the biology of tissue factor pathway inhibitor

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S200-S207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oxidative Modification of Albumin in Predialysis, Hemodialysis, and Peritoneal Dialysis Patients

By  

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c234-c240

Karger

Access to resources Recommend Favorite

Does Diabetes Mellitus Predispose to Increased Fluid Overload in Peritoneal Dialysis Patients?

By  

Nephron Clin Pract, Vol. 114, Iss. 1, 2009-10 ,pp. : c60-c66

Karger

Access to resources Recommend Favorite

Increased protein oxidation and decreased expression of nuclear factor E2‐related factor 2 protein in skin tissue of patients with diabetes

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 2, 2015-03 ,pp. : 192-200

John Wiley & Sons Inc

Access to resources Recommend Favorite